纵横研报
Ticker Detail

600594.SHG

¥3.49+0.58% 益佰制药 Drug Manufacturers - Specialty & Generic
00Reports China 医疗健康
Guizhou Yibai Pharmaceutical Co Ltd
医疗健康 · 专科与仿制药

Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells novel pharmaceutical products in China. The company offers products in the form of capsules, tablets, granules, syrups, small-volume injections, freeze-dried powder injections, lyophilized powder injections, dripping pills, and oral solutions in the areas of tumor system, cerebrovascular and cardiovascular, respiratory system, rheumatic bone, digestive system, pediatric, anti-infection, anti-inflammatory, gynecological, tonic, oncology, orthopedics, gastroenterology, andrology and urology. Guizhou Yibai Pharmaceutical Co., Ltd. was founded in 1995 and is based in Guiyang, China.

MARKET 市值 2.63B CNY 52W ¥2.85 – ¥5.27 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY -28.4% ROE -14.6% 营业利润率 -1.7% 净利润率 -20.3%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制